1. Bradykinin (Bk; Argl-Pro2-Pro3-Glya-PheS-Ser6-ProT-PheS-Arg8) inactivation by bulk isolated neurons from rat brain is described.
INTRODUCTION
Bradykinin (Bk) 4 has been suggested to play a role as a neuromodulator and/or neurotransmitter in the CNS (Snyder, 1980; Kariya et al., 1985) on the basis of several lines of evidence, such as biological activity, localization and distribution, and interaction with a specific receptor. Moreover, all the components of a kallikrein-kinin system, which include kallikrein (Chao et al., 1983) , kininogen (Shikimi et al., 1973) , kinin-converting (Camargo et al., 1972) , and Bkinactivating (Carvalho and Camargo, 1981; cf. Orlowski, 1983) activities, and Bk (Corr~a et al., 1979; Perry and Snyder, 1984; Kariya et al., 1985) have been identified in the mammalian CNS.
Bk is rapidly inactivated after intracerebroventricular injection (half-life, 26.6 sec) (Kariya et al., 1982) , and its major inactivation mechanism appears to occur through peptide bond cleavage. Bk neuronal inactivation has been approached in vitro using homogenate preparations, purified peptidases, and cloned cell cultures, among other systems. Regarding the latter system, two cell lines from neural origin (neuro-2a neuroblastoma and C8 glioma clones) were recently employed to study Bk inactivation (DelBel et al., 1986) . Although cell lines can provide useful models to study Bk enzymatic processing, it should be pointed out that they represent a transformed cell system. In this study, we have employed a preparation of bulk isolated neuronal perikarya (Sellinger et al., 1971) from rat brain that is essentially devoid of nonneuronal cell types. This preparation was used to investigate the enzymatic mechanisms of Bk inactivation. and AMC (7-amino-4-methyl-coumarin) were from Peptide Institute. Aminex A-5 and Durrum DC-6A resins were from Bio-Rad Laboratories and Durrum Chemical, respectively. All chemicals used for the amino acid analyzer buffer and ninhydrin solutions were from Pierce Chemical. Polyvinylpyrrolidone and bestatin were from General Aniline and Film and Sigma Chemical, respectively. Bovine serum albumin was fraction V from Pentex. MK 422 (N- 
MATERIALS AND METHODS

Materials
[
Isolation of Neuronal Perikarya
Neuronal cell bodies were bulk isolated from brains of 18-day-old rats, according to a modification of the procedure of Sellinger et al. (1971) . Brains from 13 Wistar rats were placed on an ice-cooled plate and cerebral cortices were dissected. The tissue (8.6 g wet weight) was minced using a razor blade, and 8.1 g was transferred into 120ml ice-cold 7.5% (w/v) polyvinylpyrrolidone solution containing 1% (w/v) bovine serum albumin and 10 mM CaCIa (solution I). The mince was sieved through nylon bolting cloth (Tobler, Ernest and Traber, Elmsford, N.Y.) of 333-, 110-and 73-/urn pore size. The volume of the last filtrate was brought to 130 ml with ice-cold solution I. Aliquots (20 ml) of the filtrate were layered on a two-step gradient (7 ml 1.0 M sucrose and 6 ml 1.75 M sucrose) and centrifuged at 41,000g for 30 min at 4°C, using a Beckman SW27 rotor. The pellet consisted of purified neuronal perikarya and its purity was assessed by phase-contrast microscopy. In fields comprising more than 50 structured particles, about 90% were neuronal perikarya. Contaminating structures consisted of bare nuclei and occasional capillary threads. Glial cells were not detected. Neuronal perikarya yield was (4.45:0.45)× 106cells/g wet brain cortex (mean+SE; N = 5). Each neuronal pellet was either suspended in 2.0ml/pellet of 0.05 M Tris-HC1 buffer, pH 7.5, containing 0.32M sucrose, and homogenized using a Potter-Elvehjem homogenizer for use on the same day or rapidly frozen to -70°C, stored at -20°C, and used within 1 week. Soluble and particulate fractions were prepared by centrifuging the homogenate at 105,000g for 1 hr at 4°C.
Prolyl Endopeptidase Assay
Prolyl endopeptidase (PE) activity was determined by a modification (Martins et al., 1987) of the procedure of Kato et al. (1980) . Initial rates (two or three time points) of AMC release were measured by incubating 3.3mM N-suc-Gly-Pro-MCA with the neuronal perikarya homogenate or homogenatederived fraction in 100 #1 0.05 M Tris-HC1 buffer, pH 7.5, containing 0.1 M NaC1 and 2 mM dithiothreitol (DTT), at 37°C for up to 30 min. The homogenate was preincubated with 2 mM DT-F at 37°C for 5 min before the addition of substrate. The reaction was stopped by the addition of 2.0 ml 1.0 M sodium acetate buffer, pH 4.2, per 100 #1 incubation medium. AMC was determined with an Aminco Model 125 spectrophotofluorometer at 380-nm excitation and 460-nm emission wavelengths on the supernatant (8300g for 10 min) of the acidified incubation medium. Blanks were prepared in the same manner as the incubates, except that 1.0 M sodium acetate buffer, pH 4.2, was added before the homogenate (zero time of reaction). Standard curves (0.3-3.0 nmol AMC/100/~1) presented a linear relationship between fluorescence intensity and AMC concentration. Homogenate (up to 50 #1) did not change the standard curve slope. In experiments designed to determine adequate assay conditions for measuring rat brain PE activity, it was shown that PE specific activity in a brain homogenate was maximal at a 2.5mM substrate concentration. AMC release was linearly related to incubation time from 10 to 120 min, for 11-82/zg homogenate protein, and PE specific activity was independent of homogenate protein concentration in the above range. All measurements were carried out in duplicate. PE specific activity is expressed as nanomoles of AMC released per minute per milligram of protein.
Kininase Bioassay
The kininase bioassay (Camargo et al., 1972) measures the rate of hydrolysis of the first peptide bond cleaved in Bk, because the hydrolysis of any peptide bond in the molecule leads to products essentially devoid of spasmogenic activity upon the isolated guinea pig ileum (Suzuki et al., 1969) . Initial Bk inactivation rates (two to four time points) were measured incubating 116 ~M Bk with a neuronal homogenate or homogenate-derived fraction in 250 or 1000/~1 0.05 M Tris-HCl buffer, pH 7.5, containing 0.1 M NaC1, at 37°C, for up to 60 min. The reaction was stopped by the addition of a 50-~1 aliquot of the incubation medium to 0.95 ml 20 mM HC1. Residual Bk was determined with the isolated guinea pig ileum bathed in 10ml Tyrode buffer containing 0.14/~M atropine and 0.17/zM diphenhydramine at 37°C. Controls were prepared in the same manner as the incubates, except that HCI was added before the homogenate (zero time of reaction). Control experiments showed that Bk was stable in the presence of acidified neuronal homogenate for up to 24hr and that the incubation of homogenate in 0.05 M Tris-HC1 buffer, pH 7.5, containing 0.1 M NaCl, without Bk, at 37°C for up to 2hr did not lead to the release of material having spasmogenic activity upon the isolated guinea pig ileum. In experiments designed to determine adequate assay conditions for the measurement of rat brain kininase activity, it was shown that kininase activity was maximal at 100/zM Bk. Bk inactivation was linearly related to incubation time from 5 to 180rain, for 30-640/~g homogenate protein, and kininase specific activity was independent of homogenate protein concentration over a 20-fold range. All measurements were carried out in duplicate. Kininase specific activity is expressed as nanomoles of Bk inactivated per minute per milligram of protein.
Bradykinin-Product Analysis
An amino acid analyzer was used to determine Argl-Pro 3, Argl-Gly 4, Argl-Phe 5, Argl-Pro 7, Gly4-Arg 9, PheS-Arg 9, Ser6-Arg 9, PheS-Arg 9, and Gly4-Pro 7 (Oliveira et al., 1976) . Free amino acids were measured by the method of Spackman et al. (1958) . The incubation conditions used for Bk-product analysis were similar to those used for the kininase bioassay, unless otherwise stated~ and the reactions were stopped by the addition of 1.2 ml/ml incubation medium of a solution containing 69% (v/v) 0.2 M sodium citrate, pH 2.2, 1% (v/v) 6 M HC1 and 30% (v/v) polyethylene glycol 400. Sample cleanup before amino acid and peptide analysis was carried out by filtration of the hydrolysate supernatant (8300g for 10 min) through a 0.45-#m filter (Millipore) . The values reported for free amino acids were corected for the blank values obtained by incubating the homogenate or homogenate-derived fractions with or without peptidase inhibitors but without Bk. Control experiments showed that homogenate did not release material that eluted with the elution volume of the peptide standards.
Dialysis
Dialysis tubing (8/32 Nojax Visking Casing) was freed from contaminating substances according to the procedure of McPhie (1971) . Water was purified using a four-cartridge Milli-Q system (Waters). Purified water (resistivity ->10Mf2-cm) showed the following metal concentration (g/liter), measured by atomic absorption spectrophotometry, <4.5 × 10 -8, zinc, and 1.1 × 10 -7, calcium, and was used for the preparation of all solutions. The neuronal perikarya-soluble fraction was treated as described in the legend to Fig. 4 .
DNA Determination
DNA was measured by the procedure of Croft and Luban (1965) , using highly polimerized calf thymus DNA (California Corp. Biochemical Research) as the standard.
Protein Determination
Protein was measured by a modification (Bensadoun and Weinstein, 1976) of the method of Lowry et al. (1951) , using bovine serum albumin as the standard.
RESULTS
Time Course of Bradykinin-Product Formation
The only peptide products detected at 10 min of Bk inactivation by the neuronal perikarya homogenate (Fig. 1A) were the complementary fragments Argl-Phe51 Ser6-nrg9, Argl-Pr07 I Phe8-Arg9, and Argl-Gly41 PheS-Arg 9. At this time (about 10% bradykinin inactivation), the stoichiometry of the complementary peptide products Argl-Phe51 Ser6-Arg8 and ArgO-Pro7 I PheS-Arg9 was essentially 1:1, whereas ArgLGly 4 and PheS-Arg 9 were recovered in the molar proportion 1:0.2. The recovery of the hydrolysis products accounted for 117% of the Bk inactivated. These results indicate that isolated neurons hydrolyze Bk at the PheS-Ser 6, Pro7-Phe 8, and Gly4-Phe 5 peptide bonds. The initial rate of PheS-Ser 6 bond cleavage was about five fold higher than that of the Pro7-Phe 8 and Gly4-Phe 5 bonds. At >10% Bk inactivation, low amounts (<0.05mol/mol Bk inactivated) of Gly4-Arg 9, Gly4-Pro 7, and Ser6-Pro 7 were detected, whereas the low-color yield peptide Argl-Pro 3, which is complementary to Gly4-Arg 9, was detected only at 40 and 60 min of incubation (<0.05 mol/mol Bk inactivated). These results suggest that isolated neurons also hyrolyze Bk at the Pro3-Gly 4 bond. The rates of release of arginine and, to a lesser extent, phenylalanine during Bk inactivation (Fig. 1B) were much higher than those of glycine, serine, and proline. The profile of free amino acids released from Bk by isolated neurons is similar to that by neuro-2a neuroblastoma but not to that by C8 glioma cells (DelBel et al., 1986) .
Processing of BK Hydrolysis Products
The increase in the relative amounts of free amino acids during Bk inactivation (Fig. 1B) , concomitantly with a variation of the rate of release and a loss of the 1: 1 stoichiometry of the complementary peptide products (Fig. 1A) , was due to proteolytic processing of the primary hydrolysis products, possibly by endopeptidases and exopeptidases. Indeed, Table I shows that, in addition to the release of free amino acids, isolated neurons catalyzed the conversion of some primary inactivation products into shorter-chain primary and secondary peptide products. Thus, Argl-Pro 7 was extensively degraded to Argl-Phe 5 and, to a lesser extent, to Ser6-Pro 7 and Gly4-Pro 7. The major peptide fragments formed from Gly4-Arg 9 were Ser6-Arg 9 and Glya-Pro 7, and that from PheS-Arg 9 was Ser6-Arg 9. Ser6-Arg 9 and Phe8-Arg 9 were almost completely degraded to free amino acids. At incubation times shorter than 30 min, in addition to free amino acids, Ser6-Pro 7 and PheS-Arg 9 were released from Ser6-Arg 9 by neuronal perikarya homogenate (data not shown), indicating that the homogenate hydrolyzes the Pro-Phe bond of Ser-Pro-Phe-Arg. In general, the N-terminal products of Bk inactivation were more resistant to degradation than the C-terminal fragments, possibly due to their Pro-Pro moiety. Table II shows that the metal chelator 1,10-phenanthroline exhibited a concentration-dependent inhibition of kininase activity, which was 93% inhibited by 1 mM chelator. In contrast, the other chelators used exerted either a slight (1 mM 8-hydroxyquinoline) or no (1 mM EDTA and 1 mM EGTA) inhibitory effect on kininase activity. PE activity was affected in the same manner as kininase activity by metal chelators. DTT (up to 2 mM) did not appreciably affect kininase activity, while it slightly activated PE activity. Both activities were strongly inhibited by 1 mM PCMB. The serine protease inhibitor diisopropylfluorophosphate (DFP; 0.2 mM) inhibited 7 and 99% kininase and PE activities, respectively, cF-Ala-Ala-Phe-pAB, an inhibitor of endopeptidase 24.15 (Chu and Orlowski, 1984) , presented a concentration-dependent inhibition of kininase activity (data not shown), which was 90% inhibited by i mM inhibitor. Maximal inhibition (75%) of kininase activity by antiserum was attained at 16/~1 antiserum/ml incubation medium. Z-Pro-prolinal (10/zM), a PE inhibitor (Wilk and Orlowski, 1983) , inhibited 98% neuronal perikarya PE but did not appreciably affect kininase activity. Bestatin (50/~M), an aminopeptidase inhibitor, did not affect kininase activity. Table III shows that 1,10-phenanthroline exhibited a concentrationdependent inhibitory effect on the release of the complementary peptide products 37°C ) with or without (control) inhibitor in 0.5 ml 0.05 M Tris-HC1 buffer, pH 7.5, containing 0.1 M NaCI, and incubation (up to 30 min, 37°C) was started by the addition of either l16#M bradykinin (kininase assay) or 3.3 mMN-suc-Gly-Pro-MCA (PE assay). The incubations were stopped by acidification. Kininase and PE activities were determined by bioassay and fluorimetry, respectively. The average values of four (kininase) and two (PE) determinations, which differed by 20% or less and 6% or less, respectively, are reported. Antiserum, endo-oligopeptidase A antiserum; nd, not determined.
Effect of Peptidase Inhibitors on Bk Processing
A r g l -P h e S l S e r 6 -A r g 9 and Argl-Pr07 ]PheS-Arg 9 and of Ser6-Pro 7 and free amino acids from BK. The formation of peptide products was essentially abolished by 1 mM 1,10-phenanthroline. E D T A (1.0mM) and DFP (0.2mM) did not inhibit the formation of A r g l -P h e 5 [ Ser6-Arg 9 but partially blocked that of Argl-Pr07 [ PheS-Arg 9, Ser6-Pro 7, and free amino acids. The formation of Argl-Phe5 [ Ser6-Arg 9 was essentially abolished by 0.1 mM PCMB, while the release of ArgX-Pro 7 was about 2.5-fold increased and that of PheS-Arg 9, SerS-Pro 7, and free amino acids decreased. The PCMB inhibition of Arg 1-Phe5 [ Ser6-Arg 9 release was almost completely reversed by 0.5 mM D T F , and that of PheS-Arg 9, Ser6-Pro 7, and free amino acids was partially reverted, but the formation of ArgO-Pro 7 was strongly inhibited, c F -A I a -A l a -P h e -p A B , an inhibitor of the soluble (Chu and Orlowski, 1984) and membrane-bound (Acker et al., 1987) forms of endopeptidase 24.15 blocked the release of Arg ~-PheSlSer6-Arg 9 in a concentration-dependent manner (inhibition > 9 0 % by l mM inhibitor), whereas the concentration of A r g l -P r o 7 increased up to 5.2-fold, and that of Phe8-Arg 9, Ser6-Pro 7, and free amino acids decreased as the inhibitor concentration increased. Rat brain endo-oligopeptidase A antiserum, which exhibits anticatalytic activity against endo-oligopeptidase A (Camargo et al., 1987; Toffoletto et al., 1988) , strongly blocked the release of Arg 1-Phe 5 ] Ser6-Arg 9, increased twofold the concentration of A r g l -P r o 7, and decreased that of PheS-Arg 9, Ser6-Pro 7, and free amino acids. A twofold increase in antiserum concentration did not lead to a further decrease in Argl-Phe5 I Ser6-Arg 9 formation. Endopeptidase 24.11 inhibitor cF-Phe-pAB (0.1 raM) (Almenoff and Orlowski, 1983 ) strongly inhibited the formation of Argl-Pro 7, PheS-Arg 9, Ser6-Pro 7, and free amino acids but increased 21% the Ser6-Arg 9 concentration without affecting that of Arg~-Phe 5. MK 422 and Z-Pro-prolinal, inhibitors of ACE (Patchett et al., 1980) and PE (Wilk and Orlowski, 1983) , respectively, exhibited inhibitory effects on the release of Bk fragments which were qualitatively similar to those of cF-Phe-pAB, but less intense, except that the Ser6-Arg 9 concentration was not affected or decreased slightly. MK 422 (0.1 mM) and Z-Pro-prolinal (10 #M) blocked 56 and 40% respectively, the formation of ArgX-Pro 7.
Effect of Peptidase Inhibitors on Ser-Pro-Phe-Arg Degradation
Ser6-ProT-Phe8-Arg 9, which is one of the primary products of Bk inactivation, contains the Pro-Phe bond that was primarily cleaved in Bk (cf. Fig. 1A ) and was extensively degraded by the neuronal perikarya homogenate (cf. Table  1 ). Therefore, we have studied the effect of peptidase inhibitors on the proteolytic processing of this tetrapeptide by the neuronal homogenate. Figure 2 , left, shows that 50/~M bestatin led to a sixfold increase in Phe-Arg release, while the phenylalanine and arginine concentrations decreased 94 and 78%, respectively. These results indicate that the hydrolysis of Phe-Arg was catalyzed to a large extent by a bestatin-sensitive aminopeptidase. Since arginine release was 4.4-fold higher than that of phenylalanine in the presence of bestatin, the involvement of a carboxypeptidase in arginine release from Ser6-Arg 9 cannot be excluded. The effect of peptidase inhibitors on Pro-Phe bond hydrolysis was studied by measuring the release of Phe-Arg from Ser6-Pro7-PheS-Arg9 in the presence of 50/tM bestatin. Figure 2 , right, shows that with 50/~M bestatin, the formation of Phe-Arg from Ser6-Arg 9 was 52, 27, and 22% inhibited by 0.1 mM cF-Phe-pAB, 0.1 mM MK 422, and 0.1 mM Z-Pro-prolinal, respectively. A mixture of these four inhibitors, at the above concentrations, abolished the release of Phe-Arg.
Characterization of the Major Bradykinin-lnactivating Endopeptidase Activity in Neuronal Perikarya
Occurrence in the Neuronal Soluble Fraction Table IV documents the levels of kininase and PE activites in isolated neurons. The values of kininase and PE specific activities in the neuronal perikarya homogenate corresponded to 4.2 + 0.56 and 0.4 + 0.07 (aveage +SE; N = 9), respectively, when expressed as femtomoles per minute per cell body. The yields of kininase and PE activities in the neuronal perikarya homogenate (relative to brain cortex, taken as 100%), were 1.9 +0.2% and 0.4+0.05% (N = 9), respectively. Kininase activity recovery was 1.7-fold higher in the soluble (105,000g for i hr) than in the particulate fraction, whereas the distribution of PE activity was about the same in these fractions. These results suggest that a Kininase and prolyl endopeptidase activities were measured by bioassay and fluorimetry, respectively. Recoveries are reported relative to the total recovered activity 1100% I in the soluble and particulate fractions. The yields relative to homogenate for kininase and prolyl endopeptidase activities were 121 and 119%, respectively. The average values +SE of five independent determinations are reported.
neuronal perikarya kininase activity is mainly cytosoluble, in agreement with subcellular distribution studies carried out with whole brain (Camargo and Graeff, 1969) . However, kininase activity is predominantly particulate in exponentially growing neuro-2a neuroblastoma cells (DelBel et al., 1986) . Neuronal PE activity is not predominantly cytosoluble, in contrast to the enzyme distribution reported using whole brain (Dresdner et al., 1982) but not to that described in neuro-2a neuroblastoma cells (DelBel et al., 1986) . A product-analysis of Bk degradation by soluble and particulate fractions of isolated neurons (data not shown) showed that the peptide-and amino acidproduct composition of their hydrolysates was similar to that of the parent homogenate. The PheS-Ser 6 bond cleavage accounted for more than 95% of Bk inactivation by the soluble fraction, on the basis of the relative amounts of the complementary peptide products formed. Taken together, the above results and the data in Table IV suggest that the major neuronal Bk inactivating cleavage is catalyzed by a cytosoluble endopeptidase activity which hydrolyzes the PheS-Ser 6 peptide bond.
Effect of Peptidase Inhibitors
The susceptibility of the Phes-Ser 6 bond hydrolysis by the soluble neuronal fraction to peptidase inhibitors was studied next. Figure 3 shows that 0.5 mM DTr did not affect the release of the complementary peptide products Arg 1-Phe 5 [ Ser6-Arg 9 from Bk, whereas 0.1 mM PCMB inhibited 97% the formation of these products. The inhibition of the Phes-Ser 6 bond cleavage by 0.1 mM PCMB was surmountable by 0.5 mM DTI'. Kininase activity in a soluble fraction dialyzed against 1.0 mM Tris-HC1 buffer, pH 7.0, for 48 hr at 4°C, was activated by DTT in a concentration-dependent manner (data not shown). Activation was maximal (about twofold) at 0.5mM DTI? and decreased with higher DTT concentrations. At 2.0mM DTI" there was essentially neither activation nor inhibition of enzyme activity. These results indicate a requirement of a thiol group for enzyme activity. DFP (0.2mM) did not affect the endopeptidase activity. Chelating agents differentially affected the PheS-Ser 6 bond cleavage. Thus, 1,10-phenanthroline exhibited a concentration-dependent inhibitory effect (>90% inhibition by 1.0mM), whereas EDTA (1.0mM) did not affect the peptidase activity. Both cF-Ala-Ala-Phe-pAB and antiserum inhibited the Phes-Ser 6 bond hydrolysis in a concentration-dependent manner, and the activity was about 90% blocked by 1.0 mM inhibitor and 20 ~tl antiserum/ml.
Effect of Metal Ions
Since metal chelators differentially effected the PheS-Ser 6 bond cleavage (Table III and Fig. 3) , it was not clear whether or not this enzyme activity is metal dependent. In order to address this issue, the effect of dialysis of the neuronal soluble fraction against 1,10-phenanthroline and EDTA and against chlorides of divalent cations on kininase activity was studied. PE activity was also studied because the brain enzyme has been shown not to be a metalloprotease (cf. Orlowski, 1983) ; it occurs in the neuronal soluble fraction (cf . Table IV) concentrations of Arg -Phe and Ser -Arg released are reported as the percentage of those formed without inhibitor (39 and 31nmol/ml, respectively), taken as 100%. Inhibitor concentrations are reported as millimolar, except for those of antiserum, which are reported as microliters of antiserum per 250/ul of incubation medium. In a control experiment, it was shown that the concentrations of PCMB and DTF used here were the lowest concentrations that, upon preincubation (15min, 37°C), essentially fully inhibit (0.1mM PCMB) and completely restore (0.5 mM DTT) the PCMB-inhibited kininase activity in a neuronal soluble fraction, oP, 1,10-phenanthroline; antiserum, rat brain endo-oligopeptidase A antiserum.
is affected by metal chelators (cf . Table II) similarly to the soluble endopeptidase activity which hydrolyzes the PheS-Ser 6 bond of Bk (cf. Fig. 3 ). Figure 4A shows that the complete inhibition of the kininase activity in the soluble fraction by dialysis against 1.0 mM 1,10-phenanthroline was more than 95% reverted upon removal of the chelator by dialysis against 1 mM Tris-HCl buffer, pH 7.0; these dialysis procedures led to about a 20% decrease in PE activity. In contrast (cf. Fig. 4B ), kininase activity was not affected by dialysis against 1 mM EDTA, whereas PE activity was about 40% activated. Figure 4A also shows that dialysis of the 1,10-phenanthroline-treated soluble fraction against 0.1 mM CaCI2 led to 33 and 48% activation of kininase and PE activities, respectively, whereas dialysis against 0.1 mM COC12 did not essentially affect or only slightly activated both kininase and PE activities. ZnCIa (0.1 mM) led to about 55% inhibition of both enzyme activities. The removal of excess and loosely bound metal ions by dialysis against 1.0 mM Tris-HC1 buffer, pH 7.0, essentially reverted the activating and inhibitory effects of metal ions on kininase activity, whereas PE activation by CaCI2, but not inhibition by ZnCI~, was reverted. Similar experiments, except that 1.0mM EDTA replaced 1.0mM 1,10-phenanthroline, led to comparable results with respect to the metal ion effect (data not shown). Alternatively, the neuronal soluble fraction was dialyzed and prolyl endopeptidase (El) activities in a neuronal perikarya-soluble fraction. Kininase and PE activities in each dialysis-treated soluble fraction are reported relative to their specific activities in a soluble fraction dialyzed for the same time against 1.0 mM Tris-HCl buffer, pH 7.0 (controls), which were taken as 100%. Kininase and PE activities were determined (in the presence of 0.5 and 2.0 mM dTT, respectively) by bioassay and fluorimetry, respectively. (A) Soluble fraction (5.0ml) was dialyzed at 4°C against four changes of 500ml 1.0mM 1,10-phenanthroline in 1.0 mM tris-HCl buffer, pH 7.0, for 24 hr (D1), and then against four changes of 500 ml 1.0 mM Tris-HC1 buffer, pH 7.0, for 24 hr (D2). The resulting retentate was divided in three equal parts. Each part was dialyzed against two changes of 250 ml of 0.1 mM CaCI 2, or 0.1 mM COC12, or 0.1 mM ZnCI z in 1,0mM Tris-HCl buffer, pH 7.0, for 24 hr (D3), and then against six changes of 250 ml of 1.0 mM Tris-HCl buffer, pH 7.0, for 48 hr (D4). (B) Same procedure as for D1 in A, except that 1.0 mM EDTA was substituted for 1.0 mM 1,10-phenanthroline (DI*). against 1.0 mM EDTA, pH 7.0, and then against 1.0 mM Tris-HC1 buffer, pH 7.0. The preincubation (15 min, 37°C) of this EDTA-treated fraction with 1.0 mM CaCI2 or with 25 ~tM ZnC12 led to 60% activation or 40% inhibition of kininase activity, respectively.
DISCUSSION
The present study shows that rat brain neuronal perikarya contain peptidases able to inactivate Bk through hydrolysis of the PheS-Ser 6, ProT-Phe 8, Gly4-Phe s, and Pro3-Gly 4 peptide bonds (cf. Fig. 1 and Results). There is strong evidence that each of the four inactivating cleavages of Bk by the neuronal perikarya homogenate was catalyzed by a different peptidase, except for the Pro7-Phe 8 bond cleavage, which appears to be catalyzed by at least three enzymes.
Neurnal Perikarya Inactivate Bradykinin Mainly Through Cleavage at the PheS-Ser 6 Bond by a ThioI-Endopeptidase
The hydrolysis of Bk at PheS-Ser 6 bond by the neuronal homogenate appears to be catalyzed mainly by an endopeptidase different from the multicatalytic protease complex (Wilk and Orlowski, 1980) , endopeptidase 24.15 , and endo-oligopeptidase A (Camargo et al., 1973; Carvalho and Camargo, 1981) , which hydrolyze the PheS-Ser 6 bond. Evidence to support this is as follows. The multicatalytic protease complex is strongly inhibited by 1 mM NaCI (Wilk and Orlowski, 1980 ) and in our enzyme assays 100 mM NaC1 was employed. The active site-directed inhibitor of endopeptidase 25.15, cF-Ala-Ala-Phe-pAB (1 mM) (Chu and Orlowski, 1984) , which does not inhibit endo-oligopeptidase A (Toffoletto et al., 1988) , almost completely inhibits the Phes-Ser 6 bond cleavage by the neuronal homogenate. Rat brain endooligopeptidase A antiserum, which exhibits anticatalytic and immunoprecipitating activity against endo-oligopeptidase A, but does not similarly affect endopeptidase 24.15 (Toffoletto et al., 1988) , strongly inhibits the PheS-Ser 6 bond hydrolysis by the neuronal homogenate. Endo-oligopeptidase A (Camargo et al., 1987) and endopeptidase 24.15 are strongly inhibited by both l mM 1,10-phenanthroline and 1 mM EDTA, whereas the release of Arg 1-Phe5 [ Ser6-Arg 9 from Bk by the neuronal homogenate is blocked by 1 mM 1,10-phenanthroline but not by 1 mM EDTA (cf. Table Ill ). The hydrolysis of the PheS-Ser 6 bond seems to be catalyzed by a thiol-endopeptidase (cf. Table  III) . Endo-oligopeptidase A (Oliveira et al., 1976; Camargo et al., 1987) , but not endopeptidase 24.15 Acker et al., 1987) , has been reported as a thiol-endopeptidase.
Argl-Phe 5 is also a degradation product of Argl-Pro 7 by neuronal perikarya homogenate (cf. Table I ). The inhibition of Bk PheS-Ser 6 bond cleavage by cF-Ala-Ala-Phe-pAB, antiserum, and PCMB leads to a concomitant severalfold increase in Argl-Pro 7 formation (cf. Table III ), suggesting that the same enzyme activity catalyzes the PheS-Ser 6 bond cleavage both of Bk and of its ArgX-Pro 7 moiety. Endo-oligopeptidase A does not hydrolyze Argl-Pro 7 to an appreciable extent (Oliveira et al., 1976) .
About two-thirds of the neuronal kininase activity is soluble, and more than 95% of Bk inactivation by the soluble fraction is accounted for by cleavage of the Phes-Ser 6 bond (cf. Table IV and Results). Our studies on the effect of peptidase inhibitors upon the release of Argl-Phe51 Ser6-Arg9 from Bk by the neuronal soluble fraction (cf. Fig. 3 ) provide strong evidence that a thiolendopeptidase inactivates Bk through cleavage of the PheS-Ser 6 bond and that this enzyme differs from previously described soluble peptidases which hydrolyze Bk at the same site. Thus, the nearly complete inhibition of the Phes-Ser 6 bond cleavage by 0.1mM PCMB was fully reversed by 0.5mM DTF, a DTT concentration that maximally activates the peptidase in a dialyzed soluble fraction. Both antiserum and cf-Ala-Ala-Phe-pAB almost completely inhibit thiol-endopeptidase activity in the neuronal perikarya soluble fraction.
The differential inhibitory effect of metal chelators on the PheS-Ser 6 bond cleavage exhibited by the neuronal perikarya homogenate (cf . Tables II and III) is also displayed by the soluble fraction (cf. Fig. 3 ): the PheS-Ser 6 bond cleavage is blocked by 1 mM 1,10-phenanthroline, but not by 1 mM EDTA, as it occurs with carboxypeptidase B (Folk et al., 1960) , a metalloenzyme sensitive to 1,10-pnenanthroline but not to EDTA. However, peptidases reported as nonmetalloenzymes, such as endo-oligopeptidase A (Camargo et al., 1987) and PE (Andrews et al., 1980) , can be inhibited by metal chelators. By using a dialysis-based technique (Vallee et al., 1960) , it was shown (cf. Fig. 4 and Results) that the inhibition of soluble neuronal kininase and PE activities by 1,10-phenanthroline is fully reversible upon removal of the chelator. In contrast to endopeptidase 24.15 (initially called soluble metalloendopeptidase), whose activity is abolished by dialysis against 1 mM EDTA at pH 7 and restored by the addition of Zn 2+ , the EDTA-treated neuronal soluble activity is inhibited by Zn 2+. Thus, it seems clear that the thiol-endopeptidase activity described here cannot be classified as a metalloendopeptidase. However, soluble thiol-endopeptidase activity is activated by high Ca 2÷ concentrations, suggesting a possible role of calcium in the regulation of this activity. The evidence presented here suggests that neuronal perikarya thiol-endopeptidase activity differs from that of both endo-oligopeptidase A and endopeptidase 24.15, which were reported to be two different enzymes (Camargo et al., 1987; Toffoletto et al., 1988) . Our data do not permit excluding a minor contribution of endo-oligopeptidase A and/or endopeptidase 24.15 to the cleavage of the Bk Phes-Ser 6 bond by neuronal perikarya.
Involvement of Endopeptidase 24.11, Angiotensin-Converting Enzyme, and Prolyl Endopeptidase in BK Neuronal Inactivation
Bk inactivation by the neuronal perakarya homogenate through ProT-Phe 8 bond cleavage appears to be catalyzed by at least three enzymes. Evidence to support this is as follows. The formation of the complementary peptide products ArgX-ProTlPheS-Arg9 is partially inhibited by 1 mM EDTA and completely blocked by 1 mM 1,10-phenanthroline (cf . Table III) , suggesting the involvement of metallopeptidase(s) in ProT-Phe 8 bond cleavage. The partial inhibition of this cleavage by endopeptidase 24.11 inhibitor cF-Phe-pAB (Almenoff and Orlowski, 1983; Matsas et al., 1984) and by ACE inhibitor MK 422 (Patchett et al., 1980; Matsas et al., 1984) (cf. Table III) indicates the participation of both zinc-peptidases, endopeptidase 24.11 and ACE, in ProT-Phe 8 bond hydrolysis. PE is a third enzyme seemingly to cleave the same ProT-Phe 8 bond, since the PE inhibitor Z-Pro-prolinal (Wilk and Orlowski, 1983) partially inhibits Bk ProT-Phe 8 bond cleavage (determined by Bk-product analysis; Table III ) and completely blocks PE activity (determined by fluorimetry; Table II ). The serine-enzyme inhibitor DFP partially inhibits this cleavage and completely inhibits PE activity. PCMB strongly blocks ProT-Phe 8 bond cleavage and fully inhibits PE activity. PCMB inhibition of ProT-Phe s bond cleavage is partially reversed by DTT, which activates PE activity (Table II) and (Greene et al., 1982) but inhibits ACE (Softer, 1981) and endopeptidase 24.11 (Almenoft and Orlowski, 1983) . EDTA partially inhibits ProT-Phe 8 bond hydrolysis and does not affect PE activity, whereas 1,10-phenanthroline strongly blocks both activities. The effects of chelators on neuronal ProT-Phe 8 bond cleavage and PE activity are in agreement with those described for brain PE, which is not a metalloprotease (cf. reviews by Wilk, 1983; Orlowski, 1983) . Neuronal soluble PE activity does not behave as a metalloprotease and is activated by Ca 2+ (cf .  Fig. 4) . The activation of PE by dialysis against EDTA (cf. Fig. 4) is possibly due to the removal of inhibitory heavy metal. Indeed, some laboratories routinely include EDTA in the medium used to assay PE activity (Kato et al., 1980; Hersch, 1981) . PE is a DTT-activated (Oliveira et al., 1976; Greene et al., 1982) serine-endopeptidase (Andrews et al., 1980) specifically inhibited by Z-Proprolinal (Wilk and Orlowski, 1983) . The properties of PE in neuronal perikarya homogenate described here are similar to those reported for purified brain PE (cf. Wilk, 1983) , except for calcium activation.
Bk inactivation by the neuronal perikarya homogenate through cleavage of Pro3-Gly 4 and Gly4-Phe 5 bonds seems to be catalyzed by PE and endopeptidase 24.11, respectively, as suggested: first by the evidence that both enzymes occur in the neuronal homogenate and hydrolyze the Bk ProT-Phe 8 bond (this report); and second, by the specificity of purified PE and endopeptidase 24.11, which hydrolyze the Bk Pro3-Gly 4 (Orlowski et al., 1979) and Gly4-Phe 5 (Almenoff and Orlowski, 1983) bonds, respectively, in addition to the ProT-Phe 8 bond cleavage.
The use of a time course of Bk-product formation to identify the sites of peptide bond cleavage, combined with a peptidase inhibitor paradigm, in which the effects of selective inhibitors can be attributed to the blockade of a given bond cleavage, leads to the model for the mechanism of Bk inactivation by rat brain neuronal perikarya proposed in Fig. 5 . Primary cleavages of Bk molecule should be distinguished from secondary cleavages of inactivation products. Primary cleavage at the Phe5-Ser 6 bond is due almost entirely to the action of a calcium-activated thiol-endopeptidase. Cleavage at the Bk Pro7-Phe s bond results mainly from the action of endopeptidase 24.11, ACE, and PE. The primary cleavages at Pro3-Gly 4 and Glya-Phe 5 bonds appear to result from the action of PE and endopeptidase 24.11, respectively. Secondary cleavages of Bk inactivation products are clearly demonstrated for Ser6-Arg 9, which is converted to Ser6-Pro 7 and PheS-Arg 9 by endopeptidase 24.11, ACE, and PE, and for Phe8-Arg 9, which is hydrolyzed by a bestatin-sensitive aminopeptidase.
Enzymatic degradation has been proposed as a major mechanism for the inactivation of neuropeptides. For a peptidase to exert such a role it should fulfill some requirements, which include the ability to hydrolyze a peptide bond(s) of its potential substrate(s), leading to inactive products, and appropriate localization, among others (Lynch and Snyder, 1986; Turner et al., 1985; White et al., 1985) . The ability of neuronal perikarya ACE and errdopeptidase 24.11 to inactivate Bk (this report), taken together with the neurochemical properties of these membrane peptidase (Turner et al., 1985) , suggests that they could play a role in Bk neuronal processing. Several possible roles have been proposed for PE such as neuropeptide processing (Martins et al., 1980; Oliveira et al., 1976 , cf. Wilk, 1983 , participation in intermediate steps of intracellular protein degradation Model for the mechanism of bradykinin inactivation by rat brain neuronal perikarya. Primary cleavages of bradykinin molecule are indicated by solid arrows, and secondary cleavages of inactivation products by dashed arrows. E 24.11, endopeptidase 24.11. (Oliveira et al., 1976; Camargo et al., 1979) , and participation in neural developmental processes (Kato et al., 1980; Martins and De Mello, 1985; DelBel et al., 1986; Martins et al., 1987) . Peptidases that cleave the Bk PheS-Ser 6 bond have been reported in adult brain (Oliveira et al., 1976; Orlowski et al., 1983; Camargo et al., 1987; MacDermott et al., 1987) and in neural systems used for developmental studies such as the chick retina (Martins and De Mello, 1985) and neuro-2a neuroblastoma cells (DelBel et al., 1986) , but their similarity to the thiol-endopeptidase shown here to occur in neuronal pericarya isolated from the developing rat brain is unclear. In addition to suggesting a possible participation, if any, of PE and thiol-endopeptidase in neuronal bradykinin inactivation, this report shows that bulk isolated neurons from rat brain could be used as a model to study neuronal peptide processing. 
